Design and discovery of novel conotoxins that target ion channels and receptors
针对离子通道和受体的新型芋螺毒素的设计和发现
基本信息
- 批准号:DP1096866
- 负责人:
- 金额:$ 41.81万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:Discovery Projects
- 财政年份:2010
- 资助国家:澳大利亚
- 起止时间:2010-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The national benefits that may arise include (i) new knowledge of biologically active peptides and their mode of action that will be protected through patent applications and provide a competitive edge for Australian biotechnology (ii) the training of a new generation of skilled researchers in chemical and structural biology that will sustain the biotechnology industry (iii) economic benefits from licensing and royalty returns on drug leads that may arise from this program (iv) environmental benefits from the development of more sensitive analytical methods that obviate over collection of endangered species and (v) social benefits from a reduction in suffering from diseases for which drugs are developed as a result of this program.
可能产生的国家利益包括:(i)生物活性肽及其作用方式的新知识,这些知识将通过专利申请得到保护,并为澳大利亚生物技术提供竞争优势;(ii)培养新一代化学和结构生物学方面的熟练研究人员,以维持生物技术产业;(iii)本计划可能产生的药品线索许可证和特许权使用费回报的经济效益(iv)开发更敏感的分析方法(涵盖濒危物种的收集)的环境效益和(v)由于该方案开发了药物,减少了疾病的痛苦,从而产生了社会效益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Em/Prof Paul Alewood其他文献
Em/Prof Paul Alewood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Em/Prof Paul Alewood', 18)}}的其他基金
Aquatic chemo-modulators: a novel source for potent molecular probes
水生化学调节剂:有效分子探针的新来源
- 批准号:
DP190101667 - 财政年份:2019
- 资助金额:
$ 41.81万 - 项目类别:
Discovery Projects
Deep Protein Sequencing, Structure and Quantification Facility
深度蛋白质测序、结构和定量设施
- 批准号:
LE170100192 - 财政年份:2017
- 资助金额:
$ 41.81万 - 项目类别:
Linkage Infrastructure, Equipment and Facilities
Novel cysteine-rich conotoxin frameworks from Australian cone snails
来自澳大利亚锥螺的新型富含半胱氨酸的芋螺毒素框架
- 批准号:
DP160101043 - 财政年份:2016
- 资助金额:
$ 41.81万 - 项目类别:
Discovery Projects
Novel conotoxins that target ion channels and receptors
针对离子通道和受体的新型芋螺毒素
- 批准号:
DP130103275 - 财政年份:2013
- 资助金额:
$ 41.81万 - 项目类别:
Discovery Projects
High-throughput, high resolution protein-peptide sequencing and quantification facility
高通量、高分辨率蛋白质肽测序和定量设施
- 批准号:
LE110100186 - 财政年份:2011
- 资助金额:
$ 41.81万 - 项目类别:
Linkage Infrastructure, Equipment and Facilities
Markers of milk quality in commercially produced UHT milks and milk powders
商业生产的超高温灭菌牛奶和奶粉中的牛奶质量标志
- 批准号:
LP0884051 - 财政年份:2008
- 资助金额:
$ 41.81万 - 项目类别:
Linkage Projects
Covalent Hydrogen Bond Mimetics of Helical Peptide Hormones
螺旋肽激素的共价氢键模拟物
- 批准号:
LP0560931 - 财政年份:2005
- 资助金额:
$ 41.81万 - 项目类别:
Linkage Projects
Total chemical synthesis of a redesigned enzyme, HIV-1 PR, containing an artificial tunable catalytic apparatus
重新设计的酶 HIV-1 PR 的全化学合成,包含人工可调催化装置
- 批准号:
DP0346844 - 财政年份:2003
- 资助金额:
$ 41.81万 - 项目类别:
Discovery Projects
CHARACTERISATION OF NOVEL BIOACTIVES FROM AUSTRALIAN HONEY WITH THERAPEUTIC POTENTIAL
澳大利亚蜂蜜中具有治疗潜力的新型生物活性物质的表征
- 批准号:
LP0348042 - 财政年份:2003
- 资助金额:
$ 41.81万 - 项目类别:
Linkage Projects
相似海外基金
FMO/ML-Guided Drug Design: Accelerating Novel Inhibitor Development and Drug Discovery
FMO/ML 引导的药物设计:加速新型抑制剂的开发和药物发现
- 批准号:
24K20888 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Accelerating drug discovery via ML-guided iterative design and optimization
通过机器学习引导的迭代设计和优化加速药物发现
- 批准号:
10552325 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Computer-aided design and development of isoform selective inhibitors of Casein Kinase 1
酪蛋白激酶 1 异构体选择性抑制剂的计算机辅助设计和开发
- 批准号:
10629703 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Machine Learning Phenotypic De Novo Drug Design
机器学习表型从头药物设计
- 批准号:
10762633 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Developing a computational platform for induced-fit and chemogenetic drug design
开发诱导拟合和化学遗传学药物设计的计算平台
- 批准号:
10680745 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Utility of adaptive design optimization for developing rapid and reliable behavioral paradigms for substance use disorders
利用自适应设计优化来开发快速可靠的药物滥用行为范例
- 批准号:
10637895 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
EnzyDock-based Multistate and Multiscale Tools for Covalent Drug Design
基于 EnzyDock 的多状态和多尺度共价药物设计工具
- 批准号:
10575904 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Structure-based Design of Selective Serotonin Biased Agonists as Chemical Probes for Psychedelic Potential
基于结构的选择性血清素偏向激动剂设计作为迷幻潜力的化学探针
- 批准号:
10712002 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
BEYOND BURDEN: NEW TOOLS FOR TUBERCULOSIS ANTIBIOTICREGIMEN DESIGN
超越负担:结核病抗生素方案设计的新工具
- 批准号:
10667002 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别: